top of page

Our versatile platform technology is a beacon of hope for patients in great need.

Empowering Lives with Unique CNS-directed Therapeutics

 COMPACT CELLULAR INNOVATION Small hollow fiber device loaded with genetically engineered myoblast cells

A best in class, patented, platform technology

for the local and targeted delivery of highly potent therapeutic proteins to the CNS and beyond.

ABOUT OUR TECHNOLOGY

Treating genetic disorders without gene therapies

3

tested products

5

patents

2

awards

Dedicated Team Pioneering Therapeutic Technological Advancements

ABOUT US

Launched in 2023, Release Tx builds on deep roots in pioneering allogeneic encapsulated cell therapy studies. Our team advances this technology, envisioning new treatments for genetic disorders without gene therapy.

OUR MISSION

Advancing best in class technology science, we explore new treatments for genetic and severe diseases using our patented encapsulated-cell technology, enhancing lives with unique CNS functionality and versatile applications.

OUR VISION

A team of solution architects, empowered and dedicated to achieve the best possible outcomes in any situations.

"It's not the altitude, it's the attitude."

- Scott Fischer (Everest)

OUR TEAM

With over 200 years of combined experience in drug development, we've got a well-seasoned team of available advisors who either have the answer off their head, or the brainpower to help in finding it.

OUR SUPPORT

HOW IT WORKS

Decoding Our Therapeutic Technology

Treatment areas:

CNS hereditary diseases, focusing on Metachromatic Leukodystrophy (MLD).

Latest Insights

NEWS

OUR PARTNERS

Innovative Partnerships Advancing Therapeutic Solutions

Happy healthy family

Eager to learn why our innovative protein delivery and CNS innovations are solid investments?

Invest in a unique
life-saving therapy.

bottom of page